Published
November 20, 2025
Updated
July 26, 2026
The original settlement claim period closed December 27, 2025, but the separate Future Refund Program remains open for qualifying recalls initiated after May 22, 2025.
Current Status
The original settlement claim period closed December 27, 2025, but the separate Future Refund Program remains open for qualifying recalls initiated after May 22, 2025.StatusFuture Refund Program OpenSee the current-status update above.
Claim DeadlineNo fixed current deadline postedReview the official program requirements before submitting.
Settlement FundTiered refund programApproved deductions and allocation terms may apply.
Potential BenefitOut-of-pocket refund for qualifying future recallsEligibility and payment terms apply.
What Happened?
The lawsuit alleged that purchasers lost money after certain Breckenridge-manufactured duloxetine was recalled. Breckenridge denied the claims and wrongdoing, and the court granted final approval of the settlement.Who Was Covered?
The closed settlement program covered personal or household purchases from August 4, 2020 through May 22, 2025. The separate future program covers qualifying recalled Breckenridge duloxetine purchased after that date under its current requirements.What Benefits Were Available?
The closed program offered $5, $7.50, or $10-per-prescription tiers. The future program may refund out-of-pocket costs for unused qualifying duloxetine subject to a recall initiated after May 22, 2025.Claims and Payment Information
The original settlement claims process is closed. People seeking a refund under the separate future-recall program should use the official site and follow its current documentation requirements.Official information is available at Boyer Settlement and Future Refund Program.
Important Dates
• Original claim period: October 28–December 27, 2025• Future program: Currently open for qualifying later recalls
• Minimum stated program duration: Through at least January 1, 2028
Settlement Fund and Legal Fees
Administration, legal fees, expenses, benefit payments, and other approved deductions are governed by the official documents and orders and can affect individual benefits.Case Information
Breckenridge Duloxetine Litigation2:24-cv-06514-JKS-JBC
U.S. District Court for the District of New Jersey.
Sources
• Official program or court information: Boyer Settlement and Future Refund ProgramFor more class actions keep scrolling below.
Settlement Fund
Tiered refund program
Case Title
Breckenridge Duloxetine Litigation
Case Number
2:24-cv-06514-JKS-JBC
Court
U.S. District Court for the District of New Jersey
Claim Deadline
No fixed current deadline posted
Status
Future Refund Program Open
Official Website
Boyer Settlement and Future Refund Program
